A detailed history of Putnam Investments LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Putnam Investments LLC holds 1,105,967 shares of RPRX stock, worth $29 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,105,967
Holding current value
$29 Million
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $29 Million - $32.3 Million
1,105,967 New
1,105,967 $31.1 Million
Q1 2021

May 17, 2021

SELL
$42.34 - $52.82 $28.1 Million - $35.1 Million
-664,679 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$36.12 - $50.05 $12.3 Million - $17 Million
-339,400 Reduced 33.8%
664,679 $33.3 Million
Q3 2020

Nov 16, 2020

BUY
$38.56 - $48.36 $9.31 Million - $11.7 Million
241,500 Added 31.67%
1,004,079 $42.2 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $33.9 Million - $39.7 Million
762,579 New
762,579 $37 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.5B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.